Tiziana Life Sciences Developing TZLS-501 as a Potential Treatment for Coronavirus Patients

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Tiziana Life Sciences Developing TZLS-501 as a Potential Treatment for Coronavirus Patients
(NASDAQ: TLSA) Delayed: 0.97 +0.20 (25.97%)
Previous Close $0.77    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $1.01    P/E N/A 
Day Low $0.85    EPS $ 
Volume 1,752,702